Cannabinoid modulation of cutaneous Aδ nociceptors during inflammation

Journal of Neurophysiology

Volumn 100, Issue 5, 2008, Pages 2794-2806

  Potenzieri, Carl ^a   Brink, Thaddeus S ^a   Pacharinsak, Cholawat ^a,c   Simone, Donald A ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ARACHIDONYL 2' CHLOROETHYLAMIDE; CANNABINOID; FREUND ADJUVANT; METHANANDAMIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED RESPONSE; HYPERALGESIA; IN VIVO STUDY; MALE; MECHANICAL STIMULATION; NEUROMODULATION; NOCICEPTIVE RECEPTOR; NONHUMAN; PRIORITY JOURNAL; RAT; RECORDING; SKIN INFLAMMATION; SKIN RECEPTOR; WITHDRAWAL REFLEX;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FREUND'S ADJUVANT; INFLAMMATION; MALE; NERVE FIBERS, MYELINATED; NEURAL CONDUCTION; NOCICEPTORS; PAIN MEASUREMENT; PAIN THRESHOLD; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SKIN;

EID: 57049182459     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.90809.2008     Document Type: Article

References (80)

1. Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG, Makriyannis A. (R)-methanandamide: a chiral novel anandamide processing higher potency and metabolic stability. J Med Chem 37: 1889-1893, 1994.
2. Ahluwalia J, Urban L, Capogna M, Bevan S, Nagy I. Cannabinoid 1 receptors are expressed in nociceptive primary afferent sensory neurons. Neuroscience 100: 685-688, 2000.
3. Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, Rubino T, Michalski CW, Marsicano G, Monory K, Mackie K, Marian C, Batkai S, Parolaro D, Fischer MJ, Reeh P, Kuno G, Kress M, Lutz B, Woolf CJ, Kuner R. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci 10: 870-879, 2007.
4. Amaya F, Shimosato G, Kawasaki Y, Hashimoto S, Tanaka Y, Ji RR, Tanaka M. Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist. Pain 124: 175-183, 2006.
5. Anand U, Otto WR, Sanchez-Herrera D, Facer P, Yiangou Y, Korchev Y, Birch R, Benham C, Bountra C, Chessell IP, and Anand P. Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons. Pain doi:10.1016/j.pain. 2008.06.007, 2008.
6. Andrew D, Greenspan JD. Mechanical and heat sensitization of cutaneous nociceptors after peripheral inflammation in the rat. J Neurophysiol 82: 2649-2656, 1999.
7. Bessou P, Perl ER. Response of cutaneous sensory units with unmyelinated fibers to noxious stimuli. J Neurophysiol 32: 1025-1043, 1969.
8. Bridges D, Rice AS, Egertová M, Elphick MR, Winter J, Michael GJ. Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience 119: 803-812, 2003.
9. Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain by endogenous cannabinoids. Nature 394: 277-281, 1998.
10. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63, 1994.
11. Djouhri L, Koutsikou S, Fang X, McMullan S, Lawson SN. Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C fiber nociceptors. J Neurosci 26: 1281-1292, 2006.
12. Du J, Zhou S, Carlton SM. Kainate-induced excitation and sensitization of nociceptors in normal and inflamed rat glabrous skin. Neuroscience 119: 547-562, 2003.
13. Du J, Zhou S, Coggeshall RE, Carlton SM. N-methy-D- aspartate-induced excitation and sensitization of normal and inflamed nociceptors. Neuroscience 137: 999-1013, 2003.
14. Elmes SJ, Jhaveri MD, Smart D, Kendall DA, Chapman V. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain. Eur J Neurosci 20: 2311-2320, 2004.
15. Elmes SJ, Winyard LA, Medhurst SJ, Clayton NM, Wilson AW, Kendall DA, Chapman V. Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat. Pain 118: 327-335, 2005.
16. Fox A, Kesingland A, Gentry C, McNair K, Patel S, Urban L, James I. The role of central and peripheral cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain 92: 91-100, 2001.
17. Gatley SJ, Gifford AN, Volkow ND, Lan R, Makriyannis A. 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur J Pharmacol 301: 331-338, 1996.
18. Guerrero AV, Quang P, Dekker N, Jordan RC, Schmidt BL. Peripheral cannabinoids attenuate carcinoma-induced nociception in mice. Neurosci Lett 433: 77-81, 2008.
19. Guindon J, Beaulieu P. Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combination in a model of neuropathic pain. Neuropharmacology 50: 814-823, 2006.
20. Guindon J, De Lean A, Beaulieu P. Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain. Pain 121: 85-93, 2006.
21. Guindon J, Hohmann AG. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol 153: 319-334, 2008.
22. Gutierrez T, Farthing JN, Zvonok AM, Makriyannis A, Hohmann AG. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis. Br J Pharmacol 150: 153-163, 2007.
23. Hämäläinen MM, Gebhart GF, Brennan TJ. Acute effect of an incision on mechanosensitive afferents in the plantar rat hindpaw. J Neurophysiol 87: 712-720, 2002.
24. Hillard CJ, Manna S, Greenberg MJ, DiCamelli R, Ross RA, Stevenson LA, Murphy V, Pertwee RG, Campbell WB. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Therapeut 289: 1427-1433, 1999.
25. Hilliges M, Weidner C, Schmelz M, Schmidt R, Ørstavik K, Torebjörk E, Handwerker H. ATP responses in human C nociceptors. Pain 98: 59-68, 2002.
26. Hohmann AG. Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives. Chem Phys Lipids 121: 173-190, 2002.
27. Hohmann AG, Farthing JN, Zvonok AM, Makriyannis A. 2004. Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin. J Pharmacol Exp Therapeut 308: 446-453, 2004.
28. Hohmann AG, Herkenham M. Localization of central CB1 receptors messenger RNA in neuronal subpopulations of rat dorsal root ganglion: a double-label in situ hybridization study. Neuroscience 90: 923-231, 1999.
29. Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47: 345-358, 2004.
30. Hosohata K, Quock RM, Hosohata Y, Burkey TH, Makriyannis A, Consroe P, Roeske WR, Yamamura HI. AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain. Life Sci 61: PL115-118, 1997.
31. Ibrahim MM, Deng H, Zvonok A, Cockayne DA, Kwan J, Mata HP, Vanderah TW, Lai J, Porreca F, Makriyannis A, Malan TP, Jr. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci USA 100: 10529-10533, 2003.
32. Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, Davar G, Makriyannis A, Vanderah TW, Mata HP, Malan TP, Jr. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci USA 102: 3093-3098, 2005.
33. Ibrahim MM, Rude ML, Stagg NJ, Mata HP, Lai J, Vanderah TW, Porreca F, Buckley NE, Makriyannis A, Malan TP, Jr. CB2 cannabinoid receptor mediation of antinociception. Pain 122: 36-42, 2006.
34. Johanek LM, Heitmiller DR, Turner M, Nader N, Hodges J, Simone DA. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms. Pain 93: 303-315, 2001.
35. Johanek LM, Simone DA. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury. Pain 109: 432-442, 2004.
36. Kelly S, Donaldson LF. Peripheral cannabinoid CB1 receptors inhibit evoked responses of nociceptive neurones in vivo. Eur J Pharmacol 586: 160-163, 2008.
37. Khasabova I, Harding-Rose C, Simone DA, Seybold VS. Differential effects of Cb1 and opioid agonists on two populations of adult dorsal root ganglion neurons. J Neurosci 24: 1744-1753, 2004.
38. Khasabova I, Simone DA, Seybold VS. Cannabinoids attenuate depolarization-dependent calcium influx in intermediate-size primary afferent neurons of adult rats. Neuroscience 115: 613-625, 2002.
39. Kirchhoff C, Jung S, Reeh PW, Handwerker HO. Carrageenan inflammation increases bradykinin sensitivity of rat cutaneous nociceptors. Neurosci Lett 111: 206-210, 1990.
40. Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H. The cannabinoid system and immune modulation. J Leukocyte Biol 74: 486-496, 2003.
41. Kocher L, Anton F, Reeh PW, Handwerker HO. The effect of carrageenan-induced inflammation on the sensitivity of unmyelinated skin nociceptors in the rat. Pain 29: 363-373, 1987.
42. Koltzenburg M, Bennett DL, Shelton DL, McMahon SB. Neutralization of endogenous NGF prevents the sensitization of nociceptors supplying inflamed skin. Eur J Neurosci 11: 1698-16704, 1999.
43. LaMotte RH, Thalhammer JG, Robinson CJ. Peripheral neural correlates of magnitude of cutaneous pain and hyperalgesia: a comparison of neural events in monkey with sensory judgments in human. J Neurophysiol 50: 1-26, 1983.
44. LaMotte RH, Thalhammer JG, Torebjörk HE, Robinson CJ. Peripheral neural mechanisms of cutaneous hyperalgesia following mild injury by heat. J Neurosci 2: 765-781, 1982.
45. Leem JW, Willis WD, Chung JM. Cutaneous sensory receptors in the rat foot. J Neurophysiol 69: 1684-1699, 1993.
46. Liu J, Gao B, Mirshahi F, Sanyal AJ, Khanolkar AD, Makriyannis A, Kunos G. Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J 15: 835-840, 2000.
47. Maccarrone M, Di Rienzo M, Battista N, Gasperi V, Guerrieri P, Rossi A, Finazzi-Agro A. The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem 278: 33896-33903, 2003.
48. Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agro A. Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility. J Immunol 166: 7183-7189, 2001.
49. Malan TP, Jr, Ibrahim MM, Deng H, Liu Q, Mata HP, Vanderah T, Porreca F, Makriyannis A. CB2 cannabinoid receptor-mediated peripheral antinociception. Pain 93: 239-245, 2001.
50. Massi P, Vaccani A, Parolaro D. Cannabinoids, immune system and cytokine network. Curr Pharmaceutical Design 12: 3135-3146, 2006.
51. Matias I, Pochard P, Orlando P, Salzet M, Pestel J, Di Marzo V. Presence and regulation of endocannabinoid system in human dendritic cells. Eur J Biochem 269: 3771-3778, 2002.
52. Matsuda LA, Loliat SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of cloned cDNA. Nature 346: 561-564, 1990.
53. Mbvudula EC, Rainsford KD, Bunning RAD. Cannabinoids in pain and inflammation. Inflammopharmacology 12: 99-114, 2004.
54. Meybohm P, Brand PA, Ufer M, Thiemann F, Steinfath M, Paris A, Scholz J, Bein B. Additive interaction of the cannabinoid receptor I agonist arachidonyl-2-chloroethylamide with etomidate in a sedation model in mice. Anesthesiology 108: 669-674, 2008.
55. Meyer RA, Campbell JN. Myelinated nociceptive afferents account for the hyperalgesia that follows a burn to the hand. Science 213: 1527-1529, 1981.
56. Millns PJ, Chapman V, Kendall DA. Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurons. Br J Pharmacol 132: 969-971, 2001.
57. Mitrirattanakul S, Ramakul N, Guerrero AV, Matsuka Y, Ono T, Iwase H, Mackie K, Faull KF, Spigelman I. Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. Pain 126: 102-114, 2006.
58. Munro S, Thomas KL, Abu-Sharr M. Molecular characterization of a peripheral cannabinoid receptor. Nature 365: 61-65, 1993.
59. Nackley AG, Makriyannis A, Hohmann AG. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 119: 747-757, 2003.
60. Nackley AG, Zvonok AM, Makriyannis A, Hohmann AG. Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation. J Neurophysiol 92: 3562-3574, 2004.
61. Parolaro D. Presence and functional regulation of cannabinoid receptors in immune system cells. Life Sci 65: 637-644, 1999.
62. Pertwee R, Griffin G, Fernando S, Li X, Hill A, Makriyannis A. AM630, a competitive cannabinoid receptor antagonist. Life Sci 56: 1949-1955, 1995.
63. Pogatzki EM, Gebhart GF, Brennan TJ. Characterization of Adelta- and C-fibers innervating the plantar rat hindpaw one day after an incision. J Neurophysiol 87: 721-731, 2002.
64. Potenzieri C, Harding-Rose C, Simone DA. The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms. Brain Res 1215: 69-75, 2008.
65. Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br J Pharmacol 141: 1118-1130, 2004.
66. Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Porreca F, Makriyannis A, Malan TP Jr. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology 99: 955-960, 2003.
67. Raja SN, Meyer RA, Campbell JN. Peripheral mechanisms of somatic pain. Anesthesiology 68: 571-590, 1988.
68. Ralevic V, Kendall DA, Jerman JC, Middlemiss DN, Smart D. Cannabinoid activation of recombinant and endogenous vanilloid receptors. Eur J Pharmacol 424: 211-219, 2001.
69. Richardson JD, Kilo S, Hargreaves KM. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75: 111-119, 1998.
70. Roberts LA, Christie MJ, Connor M. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Br J Pharmacol 137: 421-428, 2002.
71. Ross RA, Coutts AA, McFarlan SM, Anavi-Goffer S, Irving AJ, Pertwee RG, MacEwan DJ, Scott RH. Actions of cannabinoid receptor ligands on rat cultured sensory neurons: implications for antinociception. Neuropharmacology 40: 221-232, 2001.
72. Sagar DR, Kelly S, Millns PJ, O'Shaughnessey CT, Kendall DA, Chapman V. Inhibitory effect of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Eur J Neurosci 22: 371-379, 2005.
73. Samson MT, Small-Howard A, Shimoda LM, Koblan-Huberson M, Stokes AJ, Turner H. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J Immunol 170: 4953-4962, 2003.
74. Sokal DM, Elmes SJ, Kendall DA, Chapman V. Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetized rats. Neuropharmacology 45: 404-411, 2003.
75. Ständer S, Schmelz M, Metze D, Luger T, Rukwied R. Distribution of cannabinoid 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci 38: 177-188, 2005.
76. Torebjork HE, LaMotte RH, Robinson CJ. Peripheral neural correlates of magnitude of cutaneous pain and hyperalgesia: simultaneous recordings in humans of sensory judgments of pain and evoked responses in nociceptors with C-fibers. J Neurophysiol 51: 325-339, 1984.
77. Treede RD, Meyer RA, Raja SN, Campbell JN. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 38: 397-421, 1992.
78. Walker JM, Hohmann AG, Martin WJ, Strangman NM, Huang SM, Tsou K. The neurobiology of cannabinoid analgesia. Life Sci 65: 665-673, 1999.
79. Walker JM, Huang SM. Cannabinoid analgesia. Pharmacol Therapeut 95: 127-135, 2002.
80. Wenk HN, Brederson JD, Honda CN. Morphine directly inhibits nociceptors in inflamed skin. J Neurophysiol 95: 2083-2097, 2006.